HIV and liver disease forum: Conference proceedings

Authors


  • The meeting participants included the following individuals: The chairman was Kenneth E. Sherman, M.D., Ph.D., University of Cincinnati. The cochairs were Marion Peters, M.D., University of California, San Francisco; Michael Polis, M.D., National Institutes of Health; and Vincent Soriano, M.D., Hospital Carlos III. The speakers (invited and selected) were Miriam Alter, Ph.D., University of Texas Medical Branch at Galveston; Pablo Barreiro, M.D., Ph.D., Hospital Carlos III; Yves Benhamou, M.D., Ph.D., Department of Hepatology and Gastroenterology of Pitié-Salpêtriè Hospital, Paris, France; Edmund Bini, M.D., M.P.H., New York University School of Medicine; Jason Blackard, Ph.D., University of Cincinnati; Norbert Bräu, M.D., M.B.A., VA Medical Center; Susan Brobst, M.D., Ph.D., National Institute of Allergy and Infectious Diseases, National Institutes of Health; Nathaniel Brown, M.D., Idenix Pharmaceuticals, Inc.; Raymond Chung, M.D., Harvard Medical School; Carmen de Mendoza, Ph.D., Hospital Carlos III; Brian Edlin, M.D., Weill Medical College of Cornell University; Judith Feinberg, M.D., University of Cincinnati College of Medicine; Mariana Gerschenson, Ph.D., John A. Burns School of Medicine; Margaret Koziel, M.D., Beth Israel Deaconess Medical Center; Barbara McGovern, M.D., Tufts University School of Medicine/Lemuel Shattuck Hospital; Jeffrey Murray, M.D., Food and Drug Administration; David Oldach, M.D., University of Maryland Biotechnology Institute; Alan Perelson, Ph.D., Los Alamos National Laboratory; Marion Peters, M.D., University of California at San Francisco; Michael Alan Polis, M.D., M.P.H., National Institute of Allergy and Infectious Diseases, National Institutes of Health; Peter Revill, Ph.D., Victorian Infectious Diseases Reference Laboratory, Australia; David Rimland, M.D., VA Medical Center; Mohammed Tarek Shata, M.D., Ph.D., University of Cincinnati; Kenneth Sherman, M.D., Ph.D., University of Cincinnati; Norah Shire, M.P.H., University of Cincinnati; Vincent Soriano, M.D., Ph.D., Hospital Carlos III; Richard Sterling, M.D., Virginia Commonwealth University; Peter Stock, M.D., Ph.D., University of California at San Francisco; Daniel Suzman, A.B., National Institute of Allergy and Infectious Diseases, National Institutes of Health; Phyllis Tien, M.D., University of California at San Francisco/VA Medical Center; and Stacey Vlahakis, M.D., Mayo Clinic.

  • Potential conflict of interest: Nothing to report.

Ancillary